We’re only a week away from “Boston’s Life Science Disruptors,” and this Thursday is the last day to save $50 with our Procrastinator’s Special. Xconomy will bring together an outstanding lineup of scientific founders, executives, and investors on the evening of Thursday, Oct. 20, at the Koch Institute for Integrative Cancer Research at MIT.
This year, you’ll hear the stories behind gene editing startup Intellia Therapeutics and organ-on-a-microchip developer Emulate. Polaris Partners founding partner Terry McGuire and Harvard University professor and former Vertex Pharmaceuticals and Biogen executive Vicki Sato will talk through ways to address the gender gap in life sciences. And MIT biological engineering professor Scott Manalis will discuss a new approach for personalized medicine in cancer.
See you there!